The Pricing Evolution of Personalized Medicines
Video Categories: PricingRelated Videos
Optimal Value-Based Therapy
Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.Supported through funding from Incyte
Aspirations for the Launch of Ixazomib
Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.